Herranz-Alonso A - Search Results

1

Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease.

Hoyo-Muñoz A, Collado-Borrell R, Escudero-Vilaplana V, Bastos-Oreiro M, Herranz-Alonso A, Sanjurjo-Sáez M. Hoyo-Muñoz A, et al. J Clin Pharm Ther. 2022 Apr;47(4):548-551. doi: 10.1111/jcpt.13513. Epub 2021 Sep 12. J Clin Pharm Ther. 2022. PMID: 34514634

2

[Internal invoicing of end products manufactured by a hospital Pharmacy Department].

Caro González L, Herranz Alonso A, Pernia S, Mur Mur A, Sánchez Fresneda M, Sarobe González C, Martín Barnero M, Sanjurjo Sáez M. Caro González L, et al. Farm Hosp. 2002 Sep-Oct;26(5):266-274. Farm Hosp. 2002. PMID: 12595938 Spanish.

3

[Pharmacy].

Herranz Alonso A, Caro González L, Castillo Romera I, Sanjurjo Sáez M, Sarobe González C. Herranz Alonso A, et al. Med Clin (Barc). 2005 Mar 1;124 Suppl 1:46. doi: 10.1157/13072649. Med Clin (Barc). 2005. PMID: 15771848 Spanish.

4

[Smart infusion pumps: lights and shadows of an emerging technology].

Manrique-Rodríguez S, Fernández-Llamazares CM, Herranz-Alonso A, Sanjurjo-Sáez M. Manrique-Rodríguez S, et al. Med Clin (Barc). 2011 Sep 24;137(8):361-5. doi: 10.1016/j.medcli.2010.01.016. Epub 2010 Mar 7. Med Clin (Barc). 2011. PMID: 20211476 Spanish. No abstract available.

5

Prevalence of medication administration errors in two medical units with automated prescription and dispensing.

Rodriguez-Gonzalez CG, Herranz-Alonso A, Martin-Barbero ML, Duran-Garcia E, Durango-Limarquez MI, Hernández-Sampelayo P, Sanjurjo-Saez M. Rodriguez-Gonzalez CG, et al. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):72-8. doi: 10.1136/amiajnl-2011-000332. Epub 2011 Sep 2. J Am Med Inform Assoc. 2012. PMID: 21890872 Free PMC article.

6

Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis.

Escudero-Vilaplana V, Ramírez-Herraiz E, Trovato-López N, Alañón-Plaza E, Bellini MJ, Herranz-Alonso A, Bellón-Cano JM, Morell-Baladrón A, Sanjurjo-Sáez M. Escudero-Vilaplana V, et al. J Pharm Pharm Sci. 2012;15(3):355-60. doi: 10.18433/j33w30. J Pharm Pharm Sci. 2012. PMID: 22974785 Free article.

7

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice.

Ramírez-Herráiz E, Escudero-Vilaplana V, Alañón-Plaza E, Trovato-López N, Herranz-Alonso A, Morell-Baladrón A, Sanjurjo-Sáez M. Ramírez-Herráiz E, et al. Clin Exp Rheumatol. 2013 Jul-Aug;31(4):559-65. Epub 2013 May 27. Clin Exp Rheumatol. 2013. PMID: 23710583

8

Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes.

de Lorenzo-Pinto A, Bueno H, Herranz-Alonso A, Elizaga-Corrales J, Pérez-Sanz C, Cuéllar-Basterrechea B, Fernández-Avilés F, Sanjurjo-Sáez M. de Lorenzo-Pinto A, et al. Int J Clin Pharm. 2014 Aug;36(4):821-6. doi: 10.1007/s11096-014-9972-3. Epub 2014 Jun 20. Int J Clin Pharm. 2014. PMID: 24947557

9

Use of failure mode, effect and criticality analysis to improve safety in the medication administration process.

Rodriguez-Gonzalez CG, Martin-Barbero ML, Herranz-Alonso A, Durango-Limarquez MI, Hernandez-Sampelayo P, Sanjurjo-Saez M; iPharma. Rodriguez-Gonzalez CG, et al. J Eval Clin Pract. 2015 Aug;21(4):549-59. doi: 10.1111/jep.12314. Epub 2015 Apr 2. J Eval Clin Pract. 2015. PMID: 25847021

10

Adding value through pharmacy validation: a safety and cost perspective.

Ibáñez-Garcia S, Rodriguez-Gonzalez CG, Martin-Barbero ML, Sanjurjo-Saez M, Herranz-Alonso A; iPharma. Ibáñez-Garcia S, et al. J Eval Clin Pract. 2016 Apr;22(2):253-60. doi: 10.1111/jep.12466. Epub 2015 Nov 10. J Eval Clin Pract. 2016. PMID: 26552362

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page